GenSight withdraws U.S. listing

Gene therapy company GenSight Biologics S.A. (Paris, France) withdrew its proposed NASDAQ listing, citing market conditions.

In July 2015, the company filed to raise up to $100 million through an offering of ADSs (see BioCentury Extra, July 23, 2015). ...